Ketamine Research Studies | Party Poles

Ketamine research studies have been gaining momentum since the 1990s, with a significant surge in the 2010s, as evidenced by a study published in the Journal of Psychopharmacology in 2018, which reported a 50% response rate in treatment-resistant depression patients. The work of pioneers like Dr. John Krystal and Dr. Dennis Charney has been instrumental in shaping the field, with Krystal's 2013 study on ketamine's rapid antidepressant effects being a notable example. However, controversy surrounds the use of ketamine, with some critics, such as Dr. Peter Breggin, arguing that its risks outweigh its benefits. Despite this, researchers like Dr. Keith Ablow continue to explore its therapeutic potential, with a 2020 study published in the Journal of Clinical Psychopharmacology highlighting ketamine's efficacy in reducing suicidal ideation. With a vibe score of 8, ketamine research studies have a high cultural energy measurement, indicating significant interest and debate. As of 2022, the FDA has approved ketamine-based treatments for depression, paving the way for further research and development. The influence flow of ketamine research can be seen in the work of researchers like Dr. David Feifel, who has built upon the foundational studies of Krystal and Charney, demonstrating the propagation of ideas in the field.